Establishment Labs (ESTA) Competitors $33.41 -1.62 (-4.62%) Closing price 02/21/2025 03:59 PM EasternExtended Trading$33.40 -0.01 (-0.04%) As of 02/21/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends ESTA vs. NVST, PRCT, IRTC, WRBY, LIVN, ENOV, NVCR, TMDX, LMAT, and TNDMShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Envista (NVST), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Warby Parker (WRBY), LivaNova (LIVN), Enovis (ENOV), NovoCure (NVCR), TransMedics Group (TMDX), LeMaitre Vascular (LMAT), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Envista PROCEPT BioRobotics iRhythm Technologies Warby Parker LivaNova Enovis NovoCure TransMedics Group LeMaitre Vascular Tandem Diabetes Care Establishment Labs (NASDAQ:ESTA) and Envista (NYSE:NVST) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability. Does the MarketBeat Community prefer ESTA or NVST? Establishment Labs received 83 more outperform votes than Envista when rated by MarketBeat users. Likewise, 61.90% of users gave Establishment Labs an outperform vote while only 35.79% of users gave Envista an outperform vote. CompanyUnderperformOutperformEstablishment LabsOutperform Votes11761.90% Underperform Votes7238.10% EnvistaOutperform Votes3435.79% Underperform Votes6164.21% Which has more volatility and risk, ESTA or NVST? Establishment Labs has a beta of 1.12, suggesting that its share price is 12% more volatile than the S&P 500. Comparatively, Envista has a beta of 1.34, suggesting that its share price is 34% more volatile than the S&P 500. Which has stronger earnings & valuation, ESTA or NVST? Establishment Labs has higher earnings, but lower revenue than Envista. Establishment Labs is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEstablishment Labs$153.07M6.11-$78.50M-$2.58-12.95Envista$2.51B1.43-$1.12B-$6.49-3.22 Do institutionals & insiders believe in ESTA or NVST? 72.9% of Establishment Labs shares are owned by institutional investors. 11.4% of Establishment Labs shares are owned by insiders. Comparatively, 1.3% of Envista shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media prefer ESTA or NVST? In the previous week, Establishment Labs had 1 more articles in the media than Envista. MarketBeat recorded 5 mentions for Establishment Labs and 4 mentions for Envista. Envista's average media sentiment score of 1.11 beat Establishment Labs' score of 0.25 indicating that Envista is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 1 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envista 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate ESTA or NVST? Establishment Labs presently has a consensus target price of $60.60, suggesting a potential upside of 81.37%. Envista has a consensus target price of $20.21, suggesting a potential downside of 3.33%. Given Establishment Labs' stronger consensus rating and higher probable upside, equities research analysts clearly believe Establishment Labs is more favorable than Envista.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Envista 2 Sell rating(s) 9 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.07 Is ESTA or NVST more profitable? Envista has a net margin of -44.56% compared to Establishment Labs' net margin of -46.13%. Envista's return on equity of 3.86% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Establishment Labs-46.13% -184.55% -24.81% Envista -44.56%3.86%2.21% SummaryEstablishment Labs beats Envista on 11 of the 18 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$935.50M$10.20B$5.77B$8.98BDividend YieldN/A1.38%4.78%3.85%P/E Ratio-12.9518.2626.4618.82Price / Sales6.1143.42455.0280.40Price / CashN/A19.4144.0437.47Price / Book47.065.407.634.64Net Income-$78.50M$284.66M$3.18B$245.69M7 Day Performance-7.39%-4.34%-1.91%-2.66%1 Month Performance-7.78%-4.85%-0.19%-2.15%1 Year Performance-9.11%-13.80%16.70%12.90% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs2.6647 of 5 stars$33.41-4.6%$60.60+81.4%-6.7%$935.50M$153.07M-12.95960Upcoming EarningsNVSTEnvista3.544 of 5 stars$21.59+0.3%$20.21-6.4%-6.5%$3.71B$2.51B-3.3312,800PRCTPROCEPT BioRobotics3.2668 of 5 stars$67.61-2.4%$97.86+44.7%+28.3%$3.53B$199.84M-34.67430Positive NewsIRTCiRhythm Technologies1.1354 of 5 stars$112.11-0.1%$108.45-3.3%+6.8%$3.51B$492.68M-23.072,000Earnings ReportAnalyst ForecastNews CoverageGap UpWRBYWarby Parker2.5425 of 5 stars$25.70-2.7%$21.77-15.3%+71.6%$2.61B$669.77M-95.193,491Upcoming EarningsAnalyst ForecastLIVNLivaNova3.5803 of 5 stars$47.68+0.1%$69.17+45.1%-16.5%$2.59B$1.15B113.522,900Upcoming EarningsENOVEnovis3.4615 of 5 stars$43.89+0.4%$64.83+47.7%-29.1%$2.50B$1.71B-20.046,550Short Interest ↓Positive NewsNVCRNovoCure3.4804 of 5 stars$22.48+3.5%$32.67+45.3%+41.4%$2.43B$509.34M-16.061,453Upcoming EarningsNews CoverageTMDXTransMedics Group3.6152 of 5 stars$72.18+1.3%$122.70+70.0%-17.3%$2.42B$241.62M76.79210News CoverageGap UpLMATLeMaitre Vascular1.9524 of 5 stars$98.65+1.7%$94.63-4.1%+59.9%$2.22B$193.48M53.91490TNDMTandem Diabetes Care4.0868 of 5 stars$33.47+2.6%$53.81+60.8%+37.5%$2.20B$747.72M-17.342,400Positive News Related Companies and Tools Related Companies Envista Alternatives PROCEPT BioRobotics Alternatives iRhythm Technologies Alternatives Warby Parker Alternatives LivaNova Alternatives Enovis Alternatives NovoCure Alternatives TransMedics Group Alternatives LeMaitre Vascular Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ESTA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | Sponsored[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIEDRobert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...NewMarket Health Publishing, LLC. | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredNvidia’s Next Big Move Comes on Feb. 26Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
